Triumvira Immunologics is based in Cambridge, MA. It has raised $100M in total funding. Latest round: Series A.
Triumvira Immunologics is based in Cambridge, MA. Triumvira Immunologics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Triumvira Immunologics runs through 2021; nothing later has been disclosed. Investors on record include Leaps on Bear, Northbound Ventures, Bloomberg, Fifa Biotech, Oceanvine, C3i and 1 others. 7 distinct backers are named across the disclosed rounds.
We update the Triumvira Immunologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026